Lyell Immunopharma
Developing next-generation T-cell therapies for patients with solid tumors.
biotech
Company facts
- Founded
- 2018
- Employees
- 300
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: LYEL
Open positions
1 job
2 views 2 months ago
Director or Senior Director, Investor Relations and Corporate Communications
Open 65d North AmericaSenior
United States
Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies.…
Agile Regulatory Compliance